Inventor
EVNIN LUKE
US28 patents
⚠️ This page may combine multiple inventors who share the name “EVNIN LUKE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HARPOON THERAPEUTICS INC
10 patentsUS9708412B2Jul 18, 2017
Trispecific binding proteins and methods of use
HARPOON THERAPEUTICS INC66 citations97
US10100106B2Oct 16, 2018
Single domain serum albumin binding protein
HARPOON THERAPEUTICS INC27 citations94
US9920115B2Mar 20, 2018
Single domain serum albumin binding protein
HARPOON THERAPEUTICS INC31 citations94
US10066016B2Sep 4, 2018
Single chain variable fragment CD3 binding proteins
HARPOON THERAPEUTICS INC34 citations93
US10954311B2Mar 23, 2021
Trispecific binding proteins and methods of use
HARPOON THERAPEUTICS INC9 citations85
US10544221B2Jan 28, 2020
Single chain variable fragment CD3 binding proteins
HARPOON THERAPEUTICS INC14 citations85
US11453716B2Sep 27, 2022
Single domain serum albumin binding protein
HARPOON THERAPEUTICS INC1 citations73
US12528859B2Jan 20, 2026
Single domain serum albumin binding protein
HARPOON THERAPEUTICS INC0 citations62
US12084518B2Sep 10, 2024
Trispecific binding proteins and methods of use
HARPOON THERAPEUTICS INC0 citations62
US11623958B2Apr 11, 2023
Single chain variable fragment CD3 binding proteins
HARPOON THERAPEUTICS INC1 citations61
WEREWOLF THERAPEUTICS INC
9 patentsUS10696724B2Jun 30, 2020
Activatable interleukin-2 polypeptides
WEREWOLF THERAPEUTICS INC18 citations93
US10696723B2Jun 30, 2020
Activatable interleukin 12 polypeptides
WEREWOLF THERAPEUTICS INC15 citations93
US11352403B2Jun 7, 2022
Activatable interleukin-2 polypeptides and methods of use thereof
WEREWOLF THERAPEUTICS INC6 citations84
US11981716B2May 14, 2024
Activatable interleukin-2 polypeptides and methods of use thereof
WEREWOLF THERAPEUTICS INC2 citations72
US11535658B2Dec 27, 2022
Activatable interleukin-2 polypeptides and methods of use thereof
WEREWOLF THERAPEUTICS INC2 citations72
US12534505B2Jan 27, 2026
Activatable interleukin-2 polypeptides and methods of use thereof
WEREWOLF THERAPEUTICS INC0 citations61
US12275769B2Apr 15, 2025
Activatable interleukin 12 polypeptides and methods of use thereof
WEREWOLF THERAPEUTICS INC0 citations61
US11453710B2Sep 27, 2022
Activatable interleukin 12 polypeptides and methods of use thereof
WEREWOLF THERAPEUTICS INC0 citations61
US11739132B2Aug 29, 2023
Separation moieties and methods of use thereof
WEREWOLF THERAPEUTICS INC0 citations57
AMPHIVENA THERAPEUTICS INC
4 patentsUS9212225B1Dec 15, 2015
Bispecific CD33 and CD3 binding proteins
AMPHIVENA THERAPEUTICS INC17 citations89
US9803029B2Oct 31, 2017
Bispecific CD33 and CD3 binding proteins
AMPHIVENA THERAPEUTICS INC11 citations81
US10738118B2Aug 11, 2020
Methods of using bispecific CD33 and CD3 binding proteins
AMPHIVENA THERAPEUTICS INC3 citations71
US10626190B2Apr 21, 2020
Bispecific CD33 and CD3 binding proteins
AMPHIVENA THERAPEUTICS INC3 citations70